Samsung Biologics and Biogen Idec announced their joint venture in December and now they’ve established it under the name of Samsung Bioepis Co. Ltd. Samsung Bioepis will be responsible to develop and market biosimilars. The venture’s R&D center will be located in Song-do Incheon, South Korea, which will help Samsung to to specialize in […]
Biologics
Samsung joins hands with Biogen Idec to develop and market Biosimilars
Samsung continues its investment in the healthcare business and this time they’ve entered into a joint venture with Biogen Idec via Samsung Biologics, a business setup in April 2011 to specialize in biopharmaceutical manufacturing. As per the agreement, Samsung will pool in $255 million of the $300 million venture picking up 85 percent stake […]